Aqr Capital Management LLC Co Diagnostics, Inc. Transaction History

Aqr Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.48 - $11.38 $641,664 - $976,221	-85,784 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$7.16 - $9.56 $312,741 - $417,571	-43,679 Reduced 33.74%	85,784 $708,000
Q1 2021 May 17, 2021	SELL	$8.52 - $19.21 $154,348 - $348,008	-18,116 Reduced 12.28%	129,463 $1.24 Million
Q4 2020 Feb 16, 2021	BUY	$9.3 - $15.19 $593,516 - $969,410	63,819 Added 76.19%	147,579 $1.37 Million
Q3 2020 Nov 16, 2020	BUY	$8.24 - $30.8 $690,182 - $2.58 Million	83,760 New	83,760 $1.14 Million

5.59M

67.5K

174K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $15.9M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.